BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35565463)

  • 1. Can We Reboot the Role of Intraperitoneal Chemotherapy in the Treatment for Gastric Cancer with Peritoneal Carcinomatosis?: A Retrospective Cohort Study Regarding Minimally Invasive Surgery Conjoined with Intraperitoneal plus Systemic Chemotherapy.
    Kim S; Lee CM; Lee D; Kim JH; Park S; Park SH
    Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis.
    Nakashima T; Arigami T; Uenosono Y; Matsushita D; Shimonosono M; Tsuruda Y; Sasaki K; Baba K; Kurahara H; Ohtsuka T
    Int J Clin Oncol; 2023 Oct; 28(10):1371-1377. PubMed ID: 37432613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study.
    Yang Z; Lu S; Shi M; Yuan H; Wang Z; Ni Z; He C; Zheng Y; Zhu Z; Liu W; Yao X; Zhang J; Li C; Yan M; Yan C; Zhu Z
    Gastric Cancer; 2024 Mar; 27(2):387-399. PubMed ID: 38143257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal chemotherapy against peritoneal carcinomatosis: current status and future perspective.
    Kitayama J
    Surg Oncol; 2014 Jun; 23(2):99-106. PubMed ID: 24721661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Cytoreductive Surgery and Early Postoperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Gastric Cancer.
    Ha KI; Bang HY; Lee JI
    Cancer Res Treat; 2003 Dec; 35(6):507-13. PubMed ID: 26680983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of intraperitoneal chemotherapy for peritoneal carcinomatosis of gastric cancer: A retrospective study from a single center.
    Men HT; Gou HF; Liu JY; Li Q; Luo DY; Bi F; Qiu M
    Oncol Lett; 2016 May; 11(5):3501-3507. PubMed ID: 27123142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
    Chia DKA; Sundar R; Kim G; Ang JJ; Lum JHY; Nga ME; Goh GH; Seet JE; Chee CE; Tan HL; Ho J; Ngoi NYL; Lee MXW; Muthu V; Chan GHJ; Pang ASL; Ang YLE; Choo JRE; Lim JSJ; Teh JL; Lwin A; Soon Y; Shabbir A; So JBY; Yong WP
    Ann Surg Oncol; 2022 Dec; 29(13):8597-8605. PubMed ID: 36070113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes.
    Yamaguchi H; Kitayama J; Ishigami H; Kazama S; Nozawa H; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Tanaka J; Nishikawa T; Otani K; Yasuda K; Ishihara S; Sunami E; Watanabe T
    World J Gastrointest Oncol; 2015 Nov; 7(11):285-91. PubMed ID: 26600928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis.
    Lee TY; Liao GS; Fan HL; Hsieh CB; Chen TW; Chan DC
    J Oncol; 2021; 2021():5459432. PubMed ID: 34804160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer.
    Canbay E; Canbay Torun B; Cosarcan K; Altunal C; Gurbuz B; Bilgic C; Sezgin C; Kaban KK; Yilmaz S; Yazici Z
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S47-S56. PubMed ID: 33968425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
    van der Kaaij RT; Braam HJ; Boot H; Los M; Cats A; Grootscholten C; Schellens JH; Aalbers AG; Huitema AD; Knibbe CA; Boerma D; Wiezer MJ; van Ramshorst B; van Sandick JW
    JMIR Res Protoc; 2017 Jul; 6(7):e136. PubMed ID: 28705789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Expression Profile-Guided Personalized Intraperitoneal Chemotherapy for Gastric Cancer Peritoneal Carcinomatosis.
    Markovich VA; Tuzikov SA; Rodionov EO; Popova NO; Tsyganov MM; Miller SV; Podolko DV; Tsydenova IA; Ibragimova MK; Litviakov NV
    World J Oncol; 2024 Apr; 15(2):298-308. PubMed ID: 38545480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
    Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal chemotherapy for locally advanced gastric cancer to prevent and treat peritoneal carcinomatosis.
    Liang H
    Transl Gastroenterol Hepatol; 2016; 1():62. PubMed ID: 28138628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
    Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O
    Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale.
    Roviello F; Caruso S; Neri A; Marrelli D
    Eur J Surg Oncol; 2013 Dec; 39(12):1309-16. PubMed ID: 24183797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis.
    Geng X; Liu H; Lin T; Hu Y; Chen H; Zhao L; Mou T; Qi X; Yu J; Li G
    Cancer Med; 2016 Oct; 5(10):2781-2791. PubMed ID: 27650694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
    Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
    Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis.
    Rihuete Caro C; Manzanedo I; Pereira F; Carrion-Alvarez L; Serrano Á; Pérez-Viejo E
    Eur J Surg Oncol; 2018 Nov; 44(11):1805-1810. PubMed ID: 30087071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.